Literature DB >> 15121720

FeII/alpha-ketoglutarate-dependent hydroxylases and related enzymes.

Robert P Hausinger1.   

Abstract

FeII/alpha-ketoglutarate (alphaKG)-dependent hydroxylases catalyze an amazing diversity of reactions that result in protein side-chain modifications, repair of alkylated DNA/RNA, biosynthesis of antibiotics and plant products, metabolism related to lipids, and biodegradation of a variety of compounds. These enzymes possess a beta-strand "jellyroll" structural fold that contains three metal-binding ligands found in a His1-X-Asp/Glu-Xn-His2 motif. The cosubstrate, alphaKG, chelates FeII using its C-2 keto group (binding opposite the Asp/Glu residue) and C-1 carboxylate (coordinating opposite either His1 or His2). Oxidative decomposition of alphaKG forms CO2 plus succinate and leads to the generation of an FeIV-oxo or other activated oxygen species that hydroxylate the primary substrate. The reactive oxygen species displays alternate reactivity in related enzymes that catalyze desaturations, ring expansions, or ring closures. Other enzymes resemble the FeII/alphaKG-dependent hydroxylases in terms of protein structure or chemical mechanism but do not utilize alphaKG as a substrate. This review describes the reactions catalyzed by this superfamily of enzymes, highlights key active site features revealed by structural studies, and summarizes results from spectroscopic and other approaches that provide insights into the chemical mechanisms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15121720     DOI: 10.1080/10409230490440541

Source DB:  PubMed          Journal:  Crit Rev Biochem Mol Biol        ISSN: 1040-9238            Impact factor:   8.250


  331 in total

1.  In vivo self-hydroxylation of an iron-substituted manganese-dependent extradiol cleaving catechol dioxygenase.

Authors:  Erik R Farquhar; Joseph P Emerson; Kevin D Koehntop; Mark F Reynolds; Milena Trmčić; Lawrence Que
Journal:  J Biol Inorg Chem       Date:  2011-01-30       Impact factor: 3.358

2.  X-ray absorption spectroscopy structural investigation of early intermediates in the mechanism of DNA repair by human ABH2.

Authors:  Nitai Charan Giri; Hong Sun; Haobin Chen; Max Costa; Michael J Maroney
Journal:  Biochemistry       Date:  2011-05-11       Impact factor: 3.162

Review 3.  A loop matters for FTO substrate selection.

Authors:  Zhifu Han; Ning Huang; Tianhui Niu; Jijie Chai
Journal:  Protein Cell       Date:  2010-07-29       Impact factor: 14.870

4.  Fe(II)-dependent, uridine-5'-monophosphate α-ketoglutarate dioxygenases in the synthesis of 5'-modified nucleosides.

Authors:  Zhaoyong Yang; Jason Unrine; Koichi Nonaka; Steven G Van Lanen
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

5.  A high-throughput SAMDI-mass spectrometry assay for isocitrate dehydrogenase 1.

Authors:  Sarah E Anderson; Natalie S Fahey; Jungsoo Park; Patrick T O'Kane; Chad A Mirkin; Milan Mrksich
Journal:  Analyst       Date:  2020-04-16       Impact factor: 4.616

Review 6.  Freeze-quench (57)Fe-Mössbauer spectroscopy: trapping reactive intermediates.

Authors:  Carsten Krebs; J Martin Bollinger
Journal:  Photosynth Res       Date:  2009 Nov-Dec       Impact factor: 3.573

7.  A Carboxylate Shift Regulates Dioxygen Activation by the Diiron Nonheme β-Hydroxylase CmlA upon Binding of a Substrate-Loaded Nonribosomal Peptide Synthetase.

Authors:  Andrew J Jasniewski; Cory J Knoot; John D Lipscomb; Lawrence Que
Journal:  Biochemistry       Date:  2016-10-07       Impact factor: 3.162

8.  Investigations on the oxygen dependence of a 2-oxoglutarate histone demethylase.

Authors:  Elena M Sánchez-Fernández; Hanna Tarhonskaya; Khalid Al-Qahtani; Richard J Hopkinson; James S O McCullagh; Christopher J Schofield; Emily Flashman
Journal:  Biochem J       Date:  2013-01-15       Impact factor: 3.857

Review 9.  Diiron monooxygenases in natural product biosynthesis.

Authors:  Anna J Komor; Andrew J Jasniewski; Lawrence Que; John D Lipscomb
Journal:  Nat Prod Rep       Date:  2018-07-18       Impact factor: 13.423

10.  Cancer-Associated IDH1 Promotes Growth and Resistance to Targeted Therapies in the Absence of Mutation.

Authors:  Andrea E Calvert; Alexandra Chalastanis; Yongfei Wu; Lisa A Hurley; Fotini M Kouri; Yingtao Bi; Maureen Kachman; Jasmine L May; Elizabeth Bartom; Youjia Hua; Rama K Mishra; Gary E Schiltz; Oleksii Dubrovskyi; Andrew P Mazar; Marcus E Peter; Hongwu Zheng; C David James; Charles F Burant; Navdeep S Chandel; Ramana V Davuluri; Craig Horbinski; Alexander H Stegh
Journal:  Cell Rep       Date:  2017-05-30       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.